Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Favipiravir in Reducing Mortality in Individuals With Ebola Virus Disease in Guinea

NCT02329054 is registered in ClinicalTrials.gov with Institut National de la Santé Et de la Recherche Médicale, France as lead sponsor.

NCT NCT02329054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02329054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Favipiravir in Reducing Mortality in Individuals With Ebola Virus Disease in Guinea
Lead sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2014
Completion date
September 30, 2015
Enrollment
126 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ebola virus disease